Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-059442
Filing Date
2021-10-05
Accepted
2021-10-05 16:35:35
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3870
  Complete submission text file 0001209191-21-059442.txt   5230
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Issuer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4546 EL CAMINO REAL SUITE 223 LOS ALTOS CA 94022
Business Address
Macfarlane Kirsten Angela (Reporting) CIK: 0001865182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40738 | Film No.: 211307201